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principal components analysis and descending hierarchical classification. Results: 
Steps 1–3: Development and adaptation of a self-reported 44-item questionnaire on 
a 0–10 scale of fears and beliefs. 5 domains established a priori: origin of the disease, 
flares, treatments, disease progression and consequences of disease. Step 4: In the 
study of 226 patients (161 RA, 65 axSpA), all dimensions were ≥ 0.79 and ≤ 0.93, apart 
from the domain “origin of the disease” (0.67). Principal component analysis identi-
fied 6 axes (63.7% of variance explained) and the descending hierarchical analysis 
identified 9 clusters (63.7% of variance). 2 clusters were highly correlated (r2= 0.80) 
and combined into a single cluster. Based on the psychometric validation, the fol-
lowing domains were identified: fears of the disease progression/consequences (18 
items) and fears about treatment (5); beliefs related to: psychological influence (2), 
genetic influence (2), physical influence (4), diet influence (4), lifestyle (3) and diverse 
opinions (4). ConClusions: This analysis confirms the internal consistency of the 
questionnaire developed. The scoring results should help physicians to understand 
their patients’ perceptions of their disease better and eventually lead to improved 
adherence to treatment.
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objeCtives: Measuring poverty in health care settings may contribute to identifying 
patients in poverty and subsequently getting appropriate management. Although 
many scales are available to measure poverty in health, less attention has been paid 
to the poverty related quality of life. The purpose of this methodological study was to 
adapt the Poverty Related Quality of Life Questionnaire developed by Boyer and others 
(2014) into Turkish and to evaluate its psychometric properties for a Turkish patient 
population. Methods: The scale was adapted into Turkish through a translation and 
back-translation process. The content validity of the scale was assessed using expert 
approval. The psychometric properties of the scale were investigated by collecting 
data from 300 patients in 3 emergency departments from random selected hospitals 
in Ankara during the period of 1 April–30 May 2015. Results: An exploratory factor 
analysis identified that the seven-factor structure accounted for 80.1% of the total 
variance. A confirmatory factor analysis indicated a sufficient model fit for the con-
struct validity of the scale: root mean square error of approximation, 0.041; compara-
tive fit index, 0.93; general fit index, 0.97; standardized root mean square residual, 
0.050. Cronbach’s alpha for the total scale was 0.83 and each item achieved the 0.40 
standard for item internal consistency. Significant associations with socioeconomic 
and clinical indicators showed good discriminant validity. ConClusions: This study 
supports the validity and reliability of the Turkish version of Poverty Related Quality 
of Life Questionnaire. This instrument can be used to measure multiple aspects of 
poverty in the health care settings; however, as poverty and quality of life are con-
textual facts, further work is needed to test the psychometric properties of this scale 
both in Turkish and different cultures.
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objeCtives: The objective of this study was to develop and validate a decision algo-
rithm that replicates expert opinion regarding the level of disease activity in patients 
with acromegaly. Methods: A panel of key experts in endocrinology and outcomes 
research provided input as to what parameters are critical to assess disease activity. 
The top five parameters where then subsequently defined at three levels of severity. 
A final set of 243 unique health states were developed. A group of 21 expert endo-
crinologists from 5 European countries and Canada was recruited to participate 
in a discrete choice experiment. Each participant was presented with 10 common 
scenarios and 42 additional scenarios selected at random and asked to indicate 
whether the hypothetical patient was stable, having mild disease activity needing 
further evaluation, or having significant disease activity requiring clinical action. 
Concordance in decisions based on the 10 common scenarios was tested using Fleiss 
Kappa and a set of linear prediction models tested to predict outcome. Results: 
The five parameters included: 1) IGF-I level (SDS score); 2) tumor status (change 
on MRI); 3) comorbidities (number and severity); 4) signs and symptoms (Patient 
Acromegaly Symptom Questionnaire score); and 5) health-related quality of life 
(scored on a disease specific measure). The Inter-rater reliability was adequate 
(Kappa = 0.52). Based on a CART analysis, the decision model of best fit was dis-
junctive with IGF-1 and Tumor status primarily predicting the health status. The 
remaining three parameters were instructive but not deterministic. ConClusions: 
Biochemical and tumor status are the primary predictors of disease activity, with 
the patient’s perceived disease state playing a secondary role. This may highlight 
the need for a more patient-centered approach to acromegaly disease manage-
ment. To enable clinical use of the model, a disease specific tool named ACRODAT 
(ACROmegaly Disease Activity Tool) is currently in further development.
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objeCtives: To assess effects of CZP+MTX vs placebo (PBO)+MTX on patient 
reported outcomes in DMARD-naïve patients with severe, active and progressive 
RA. Methods: Patients in this double-blind randomized study (NCT01519791) 
were DMARD-naïve with active RA< 1yr diagnosis at baseline (BL), fulfilling 
2010 ACR/EULAR criteria; ≥ 4 swollen and ≥ 4 tender joints; DAS28[ESR]≥ 3.2; 
CRP≥ 10mg/L and/or ESR≥ 28mm/hr, rheumatoid factor/ACPA positive. Patients 
were randomized 3:1 to CZP (400mg Wks 0,2,4 then 200mg Q2W to Wk52)+MTX 
or PBO+MTX. MTX was initiated at 10mg/wk, increased up to 25mg/wk by Wk8, 
maximum tolerated dose maintained to Wk52. HAQ-DI, PtGADA, Pain VAS, %pts 
achieving normative physical function (HAQ-DI≤ 0.5), health-related QoL (SF-36, 
EQ-5D-3L) were assessed. At Wk52 changes from baseline (CFB) were analyzed 
using ANCOVA (LOCF imputation); categorical variables were analyzed using 
logistic regression (non-responder imputation). Data are LS mean CFB (SE) unless 
otherwise specified. Results: 660 (CZP+MTX) and 219 (PBO+MTX) patients were 
randomized; 655 vs 213 in the full analysis set (patients with baseline and post-
baselineL DAS28[ESR]). Baseline characteristics were balanced between study 
arms; mean (SD) HAQ-DI= 1.6 (0.6), Pain VAS= 66.1 (22.4), PtGADA= 65.3 (22.0). 
At Wk52, greater improvements from baseline were observed with CZP+MTX 
vs PBO+MTX in HAQ-DI (-1.0 [0.0] vs -0.8 [0.0], p< 0.001; 48.1% vs 35.7% patients 
reached normative function), pain (-48.5 [1.0] vs -44.0 [1.7], p< 0.05), PtGADA (-46.7 
[1.0] vs -42.0 [12.5], p< 0.05) and health-related QoL measured by SF-36 (physical 
component summary score= 12.4 [0.4] vs 10.7 [0.6], p< 0.01; mental component 
summary score= 8.2 [0.5] vs 6.8 [0.7]). Numerically higher proportions of CZP+MTX 
patients reported no problems in domains of the EQ-5D-3L vs PBO+MTX patients, 
including mobility, self-care, usual activities, pain/discomfort and anxiety/depres-
sion. ConClusions: In DMARD-naïve patients with severe, active and progressive 
RA, CZP+MTX showed greater improvements at 1-year in physical function, pain, 
disease activity and health-related QoL compared to PBO+MTX.
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objeCtives: To carry-out the cultural adaptation into Spanish (for Spain) of the 
questionnaire “Overactive Bladder - Family Impact Measure (OAB-FIM)”. Methods: 
The adaptation included linguistic validation through forward and back transla-
tions in duplicate, reviewed by a panel experts and a debriefing with relatives of 
OAB patients, and a phase of preliminary measurement of psychometric proper-
ties in OAB patients and their relatives of habitual coexistence, of both genders, 
≥ 18 years of age, newly diagnosed and on-therapy for their symptoms of OAB. 
Conceptual and linguistic equivalences, internal consistency (α -Cronbach), con-
tent validity (the inter-rater Rovinelli-Hambleton index of item congruence) and 
construct validity were measured. Construct validity included concurrent validity 
(with scales ZARIT and OABq-SF), and validity of known groups according to the 
benefit of treatment with TBS scale. Feasibility and burden of administration were 
also measured. Results: 25 couples of patients [mean (SD): 57.2 (16.0) years, 60% 
women] and relatives [63.0 (14.3) years, 44% women] were enrolled. The OAB-FIM 
was equivalent conceptually and linguistically to the original, remaining the six 
initial domains: activities, travel, concern, irritation, sleep and sex. Missing items 
was low (2.95%). Floor and ceiling effects varied, respectively, between 20%-28%, and 
0%-16%. The average time of completion was 5.2 (2.8) minutes. 24.0% needed some 
help to complete the questionnaire. The Rovinelli-Hambleton index ranked correctly 
all items in its domain, except for the item 10 which ranked in domains irrita-
tion and concern. α -Cronbach varied between 0.948-0.839. Correlations of OAB-FIM 
with ZARIT were high-to-moderate (0.407-0.753) and moderate-to-small with the 
OABq-SF (0.004-0.423). Relatives whose patients showed treatment benefit showed 
scores lower on the scale (lowest impact). ConClusions: A Spanish version of 
the OAB-FIM conceptually and linguistically equivalent to the original has been 
obtained. The questionnaire has shown good internal consistency, content validity 
and construct validity, together with feasibility in the Spanish culture.
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objeCtives: To develop and validate a patient-reported questionnaire assessing 
the fears and beliefs of patients suffering from rheumatoid arthritis (RA) or spon-
dyloarthritis (SpA), that could improve educational programs. Methods: Step 1: 
Qualitative research (individual patient interviews: 25 RA, 25 axial SpA [axSpA]). Step 
2: All fears and beliefs appearing in more than 10% of interviews rephrased as ques-
tions by an expert group including a patient-partner. Each question scored 0–10 (10= 
higher fears/stronger beliefs). Step 3: Preliminary questionnaire tested by cognitive 
debriefing (5 RA, 5 axSpA patients), and reproducibility through a test-retest procedure 
among 28 patients (13 RA, 15 axSpA). Step 4: Psychometric validation through a cross-
sectional study of 226 patients. Internal consistency assessed by Cronbach’s alpha, 
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objeCtives: To date the focus of both development and application of HRQoL instru-
ments has been on research/clinical trials, but their application in clinical practice has 
been neglected. Therefore a PRO was conceptualized for use in clinical practice. The 
aim of this study was to explore the views of patients with haematological malignan-
cies (HM) concerning the quality of life issues important to them. Methods: Ethics 
approval was obtained from Bristol Ethics Committee. Adult patients (with myeloid 
or lymphoid neoplasm or acute leukemia according to 2008 WHO classification at any 
stage of disease) capable of reading/understanding English and able to give informed 
written consent were recruited into the study. This qualitative study employed semi-
structured interviews (face-to-face or by phone) and survey (online) with open-ended 
questions for data collection. Interviews were tape recorded and transcribed verba-
tim. Content analysis was carried out using Nvivo9. Results: 57 patients (male= 37; 
female= 20) with mean age of 61.8 (sd= 9.1) and mean duration of disease of 3.7 
(sd= 3.1) were recruited into the study. 14 of the 17 interviews were face-to-face and 
remaining 40 were online surveys. Of the 57, 46 were multiple myeloma, 8 MDS, one 
NHL and 2 AML. Issues reported by patients were grouped into two broad categories: 
symptoms; and QoL. The symptoms were grouped into 5 categories: breathlessness; 
fractures; spinal problems; anaemia and black urine. 21 QoL issues were reported by 
patients with the highly prevalent items being ‘feeling angry’, ‘avoid crowds’, ‘strain on 
relationships’, ‘unable to do any activity’ and ‘doing things slowly’. These QoL issues 
appear to be unique to such patients. ConClusions: The findings of this study 
indicate that there are certain symptoms and QoL issues that are specific to patients 
with HM and thus deserve a dedicated recognition. This also demonstrates the depth 
and breadth of the impact of HM on physical and psychosocial functional behavior.
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objeCtives: The current value set for the German version of the EQ-5D-3L was gen-
erated more than 10 years ago and there is also a demand for a new valuation study, 
because the questionnaire has been changed from a 3-level to a 5-level version. The 
aim of this study was to derive a value set for the EQ-5D-5L for Germany. Methods: 
The study design followed, as one of the first countries, the improved EQ-5D-5L valu-
ation protocol developed by the EuroQol Research Foundation. Data were collected in 
computer assisted personal interviews with members of the German general popula-
tion. Participants were asked to each value a randomly selected block of 10 EQ-5D-5L 
health states using composite time trade-off (cTTO). Econometric modelling was used 
to estimate values for all 3,125 possible health states described by the EQ-5D-5L. The 
most appropriate model was determined in terms of logical consistency, goodness 
of fit and parsimony. Results: The values for 86 selected EQ-5D-5L health states 
were elicited using cTTO from a representative general population sample (n= 1,159). 
Random effects model with main effects represented by 20 dummy variables and a 
constant performed better than the other models. This model showed high consist-
ency in the sense that the higher the dimensional level the lower the coefficient for 
all parameter estimates (p-value< 0.05). The predicted values ranged from -0.4675 to 
0.9876. ConClusions: The improved valuation protocol combined with intensive 
interviewer training and close data monitoring showed a high feasibility and accept-
ability to respondents as well as interviewers in Germany and resulted in high data 
quality. The EQ-5D-5L preference values estimated in this study might facilitate the 
use of the EQ-5D-5L in a range of applications like in cost-utility analysis for health 
care policy and clinical assessment in Germany.
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objeCtives: ASCEND is a phase 3, randomized, double-blind, placebo-controlled 
trial designed to assess whether natalizumab slows disability progression in sec-
ondary progressive multiple sclerosis (SPMS). The objective of this study was to 
use Rasch Measurement Theory (RMT) methods to evaluate the Multiple Sclerosis 
Impact Scale (MSIS-29) and MS Walking Scale (MSWS-12), patient-reported out-
come instruments assessing the impact of MS, and to explore an optimized scor-
ing structure based on empirical post-hoc analyses. Methods: Baseline blinded 
data from ASCEND (n= 889) were analyzed. In stage 1, RMT methods examined: 
scale-to-sample targeting, item fit, local dependency, and reliability. In stage 2, a 
post-hoc revision of the scoring structure (MSIS-29 and MSWS-12) and conceptual 
grouping of items (MSIS-29 only) was conducted and re-evaluated. Results: Stage 
1 showed adequate scale performance for the MSIS-29 except for item misfit (6 
Physical items; 2 Psychological items), suggesting more than two clinical concepts. 
The MSWS-12 performed psychometrically well except for disordered thresholds 
(2/12), item misfit (3/12) and mis-targeting (person location range: -5.01 to 5.77; item 
location range: -2.99 to 4.10). For stage 2, two MSWS-12 items were rescored. The 
revised MSWS-12 showed improved scale performance (i.e., response categories and 
item fit), but not targeting. The MSIS-29 was re-categorized into three conceptually 
clearer sub-scales: ‘Symptoms’; ‘Psychological’; ‘Limitations’. The revised MSIS-29 
scoring structure improved targeting and some item misfit (person location range; 
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objeCtives: Existing evidence on the psychometric properties of physical func-
tioning and pain outcomes measures used in the chronic low back pain (CLBP) 
trials are not been systematically reviewed. The objective of our study was to 
evaluate the methodological quality of studies that evaluated psychometric prop-
erties of functioning and pain outcome measures for CLBP using Consensus-based 
Standards for the selection of health status Measurement Instruments (COSMIN) 
check list. Methods: We searched Pubmed and EMBASE databases from inception 
to June 2015 with specific key words. Longitudinal cohort and cross sectional stud-
ies which included at least one assessment of psychometric property of outcomes 
measure in CLBP patients were included. Studies published in English language 
and on humans were included. Studies published as reviews, editorials and case 
reports were excluded. Two reviewers independently performed study selection, 
data extraction and quality assessment procedures; disagreements between 
reviewers were resolved through discussion. Results: A total of 32 studies met 
our inclusion criteria. In this systematic review only one third (34%) of instruments 
were tested for all psychometric properties and showed mixed methodological 
quality according to COSMIN check list. Among all instruments Quebec Back 
Pain Disability Scale had showed excellent reliability (Cronbach’s alpha coeffi-
cient 0.96) and test-retest reliability (ICC= 0.92) for physical functioning assess-
ment. Pain Catastrophising Scale had showed excellent reliability (α = 0.92) and 
high degree test-retest reliability (ICC= 0.842). More than half of the instruments 
showed excellent/good reliability and half showed fair validity. Responsiveness 
was assessed in only nine studies and had all showed fair quality. ConClusions: 
Overall we found moderate methodological quality for most of the measures to 
advise tools use based on psychometric properties. Further research is needed to 
investigate the psychometric properties of all outcome measures used in CLBP 
research.
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objeCtives: Although job-related stress has been reported to critically influence 
quality of life (QoL), few studies reported the optimum instruments to measure job-
related QoL. The aim of the study was to investigate the type and frequency of instru-
ment used to assesses the level of stress or quality of life related work. Methods: A 
systemic search of PubMed was employed to find all relevant full texts for recent 5 
years focusing on human participants. Search keywords included “job-related stress 
or work-related stress”, and “Quality of life”. Information regarding the methods 
used to quantify stress, instruments used to measure quality of life, demographic 
and professional characteristics of the target population, as well as the sample size 
was gathered. Results: 50 studies were found during study period, of which 28 
of them examined the job related stress and the QoL. Of those 28 studies, health 
care workers were most frequently studied (19), and diverse methods were used 
to quantify the level of stress, of which JCQ (Karasek’s job content questionnaire), 
was most frequently used, followed by ERI(Siegrist’s Effort-Reward Imbalance) and 
JSS(Job Stress Scale). Frequently, however, stress level was not quantified at all 
(5 out of 28 studies). Regarding QoL instruments, SF-12/36 were most frequently 
used (11 studies), followed by PROQoL(The Professional Quality of Life Scale) and 
WHOQoL(The World Health Organization Quality of Life)., yet few studies provided 
explanation regarding the selection of the methods used. ConClusions: Diverse 
methods have been used to evaluate the impact of job-related stress on the QoL, 
without proper justification. Methodologically robust studies could enhance the 
importance of job-related stress on the QoL.
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objeCtives: To compare two methods for estimation of Work Limitations 
Questionnaire scores (WLQ, 8 items) from the Role Physical (RP, 4 items) and Role 
Emotional scales (RE, 3 items) of the SF-36 Health survey. These measures assess 
limitations in role performance attributed to health (emotional, physical, or both) 
and different breadth of impact (work vs. work and other activities). We compared 
WLQ estimates based on an item response theory crosswalk (Method1) and a regres-
sion imputation (Method 2). Such estimates can expand the information from 
studies using only the SF-36 measure, and can inform future data collection strate-
gies. Methods: We used data from two independent cross-sectional panel samples 
(Sample1, n= 1382, 51% female, 72% Caucasian, 49% with preselected chronic condi-
tions, 15% with fair/poor health; Sample2, n= 301, 45% female, 90% Caucasian, 47% 
with preselected chronic conditions, 21% with fair/poor health). Method 1 used previ-
ously developed and validated IRT based calibration tables. Method 2 used regression 
models to develop aggregate imputation weights as described in the literature. We 
evaluated the agreement of observed and estimated WLQ scale scores from the two 
methods and their ability to discriminate among known groups of patients. Results: 
Estimated scores from the two methods were strongly correlated (r= .99). Estimated 
and observed scale scores had strong correlations (r= .68 for RE and r= .76 for RP). 
Observed and estimated WLQ from both methods successfully differentiated between 
levels of self reported general health and between patients with and without chronic 
conditions. For both methods the estimated WLQ means from SF36RP score were 
closer (and not statistically different for Method1) to the observed WLQ means than 
estimated WLQ scores from the SF36 RE scale. ConClusions: Our results suggest 
that both methods provide useful WLQ estimates for group level analysis. Method 1 
appears slightly more accurate than Method 2, but is computationally more complex.
